KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Change in Receivables (2016 - 2025)

Clorox (CLX) has 16 years of Change in Receivables data on record, last reported at -$38.0 million in Q4 2025.

  • For Q4 2025, Change in Receivables fell 290.0% year-over-year to -$38.0 million; the TTM value through Dec 2025 reached $53.0 million, up 453.33%, while the annual FY2025 figure was $145.0 million, 326.47% up from the prior year.
  • Change in Receivables reached -$38.0 million in Q4 2025 per CLX's latest filing, up from -$118.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $216.0 million in Q2 2025 and bottomed at -$118.0 million in Q3 2025.
  • Average Change in Receivables over 5 years is $5.5 million, with a median of $15.0 million recorded in 2023.
  • The widest YoY moves for Change in Receivables: up 1100.0% in 2025, down 290.0% in 2025.
  • A 5-year view of Change in Receivables shows it stood at -$84.0 million in 2021, then skyrocketed by 82.14% to -$15.0 million in 2022, then surged by 720.0% to $93.0 million in 2023, then crashed by 78.49% to $20.0 million in 2024, then crashed by 290.0% to -$38.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$38.0 million in Q4 2025, -$118.0 million in Q3 2025, and $216.0 million in Q2 2025.